Reaktion #471089
ord-897eccad0f6540c88169f23becfa6698
Reaktionsgleichung
sodium hydroxide
6-(3,5-dimethylisoxazol-4-yl)-2,2,4,4-tetramethyl-1,2,3,4-tetrahydro-furo[2,3-h]quinolin-3-one
pyridinium hydrobromide
→
title compound
Ausbeute 44.0%
8-bromo-6-(3,5-dimethylisoxazol-4-yl)-2,2,4,4-tetramethyl-1,2,3,4-tetrahydro-furo[2,3-h]quinolin-3-one
Ausbeute 44.0%
Edukte
Reagenzien
Keine
Lösungsmittel
Reaktionsbedingungen
Detaillierte Bedingungen
See reaction.notes.procedure_details.
Aufarbeitung
- 1Temperaturcooling
- 2Extraktionextracted with ethyl acetate
- 3WaschenThe organic layer was washed with water and saturated brine
- 4Trocknendried over sodium sulfate
- 5SonstigeThe solvent was evaporated under reduced pressure
- 6WaschenThe residue was subjected to normal phase chromatography (elution solvent hexane→hexane-ethyl acetate=3:2)
Vorschrift
To a solution of 6-(3,5-dimethylisoxazol-4-yl)-2,2,4,4-tetramethyl-1,2,3,4-tetrahydro-furo[2,3-h]quinolin-3-one (31 mg) obtained in Example 93, 3) in THF (1.0 ml) was added pyridinium hydrobromide perbromide (29 mg) under ice-cooling, and the mixture was stirred at room temperature for 1 hr. The reaction solution was neutralized with 1N aqueous sodium hydroxide solution, and extracted with ethyl acetate. The organic layer was washed with water and saturated brine, and dried over sodium sulfate. The solvent was evaporated under reduced pressure. The residue was subjected to normal phase chromatography (elution solvent hexane→hexane-ethyl acetate=3:2) to give the title compound (17 mg, 44%).